Odevixibat

Status:

Red

Decision Date:

November 2021

Comments

RED: NICE HST17 - Treatment of progressive familial intrahepatic cholestasis in patients aged ≥6 months. (Decision date - March 2022)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again